R. J. Kathawala, P. Gupta, C. R. Ashby, and Z. S. Chen, The modulation of ABC transporter-mediated multidrug resistance in cancer: A review of the past decade, Drug Resist. Updat, vol.18, pp.1-17, 2015.

S. Scales and F. De-sauvage, Mechanisms of Hedgehog pathway activation in cancer and implications for therapy, Trends Pharm. Sci, vol.30, pp.303-312, 2009.

C. R. Cochrane, A. Szczepny, D. N. Watkins, and J. E. Cain, Hedgehog Signaling in the Maintenance of Cancer Stem Cells, Cancers, vol.7, pp.1554-1585, 2015.

A. Gonnissen, S. Isebaert, C. Perneel, C. M. Mckee, F. Van-utterbeeck et al., Patched 1 Expression Correlates with Biochemical Relapse in High-Risk Prostate Cancer Patients, Am. J. Pathol, vol.188, pp.795-804, 2018.

S. Blotta, J. Jakubikova, T. Calimeri, A. M. Roccaro, N. Amodio et al., Canonical and noncanonical Hedgehog pathway in the pathogenesis of multiple myeloma, Blood, vol.120, pp.5002-5013, 2012.

K. S. Jeng, I. S. Sheen, W. J. Jeng, M. C. Yu, H. Hsiau et al., High expression of Sonic Hedgehog signaling pathway genes indicates a risk of recurrence of breast carcinoma, Onco Targets Ther, vol.7, pp.79-86, 2013.

C. Zhao, A. Chen, C. H. Jamieson, M. Fereshteh, A. Abrahamsson et al., Hedgehog signalling is essential for maintenance of cancer stem cells in myeloid leukaemia, Nature, vol.458, pp.776-779, 2009.

K. C. Queiroz, R. R. Ruela-de-sousa, G. M. Fuhler, H. L. Aberson, C. V. Ferreira et al., Hedgehog signaling maintains chemoresistance in myeloid leukemic cells, Oncogene, vol.29, pp.6314-6322, 2010.

Z. Saze, M. Terashima, M. Kogure, F. Ohsuka, H. Suzuki et al., Activation of the sonic hedgehog pathway and its prognostic impact in patients with gastric cancer, Dig. Surg, vol.29, pp.115-123, 2012.

X. Xu, H. Ding, G. Rao, S. Arora, C. P. Saclarides et al., Activation of the Sonic Hedgehog pathway in thyroid neoplasms and its potential role in tumor cell proliferation, Endocr. Relat. Cancer, vol.19, pp.167-179, 2012.

M. Bidet, A. Tomico, P. Martin, H. Guizouarn, and P. Mollat, Mus-Veteau, I. The Hedgehog receptor Patched functions in multidrug transport and chemotherapy resistance, Mol. Cancer Res, vol.10, pp.1496-1508, 2012.

M. Damaghi, J. W. Wojtkowiak, and R. J. Gillies, pH sensing and regulation in cancer, Front. Physiol, vol.17, 2013.

A. Hasanovic, Mus-Veteau, I. Targeting the Multidrug Transporter Ptch1, Potentiates Chemotherapy Efficiency, vol.7, p.107, 2018.

L. Fiorini and I. Mus-veteau, Method to Screen Multidrug Transport Inhibitors Using Yeast Overexpressing a Human MDR Transporter, Methods Mol. Biol, vol.1432, pp.303-318, 2016.

L. Fiorini, M. Tribalat, L. Sauvard, J. Cazareth, E. Lalli et al., Natural paniceins from Mediterranean sponge inhibit the multidrug resistance activity of Patched and increase chemotherapy efficiency on melanoma cells, Oncotarget, vol.6, pp.1500-1527, 2015.
URL : https://hal.archives-ouvertes.fr/hal-01445153

A. Hasanovic, C. Ruggiero, S. Jung, I. Rapa, L. Signetti et al., Targeting the multidrug transporter Patched potentiates chemotherapy efficiency on adrenocortical carcinoma in vitro and in vivo, Int. J. Cancer, vol.143, pp.199-211, 2018.
URL : https://hal.archives-ouvertes.fr/hal-02322068

R. Dummer, P. A. Ascierto, H. J. Gogas, A. Arance, M. Mandala et al., Overall survival in patients with BRAF-mutant melanoma receiving encorafenib plus binimetinib versus vemurafenib or encorafenib (COLUMBUS): A multicentre, open-label, randomised, phase 3 trial, Lancet Oncol, vol.19, pp.1315-1327, 2018.

C. J. Davis, T. E. Hurst, A. M. Jacob, and C. J. Moody, Microwave-mediated Claisen rearrangement followed by phenol oxidation: A simple route to naturally occurring 1,4-benzoquinones. The first syntheses of verapliquinones A and B and panicein A, J. Org. Chem, vol.70, pp.4414-4422, 2005.

S. Dasari and P. B. Tchounwou, Cisplatin in cancer therapy: Molecular mechanisms of action, Eur. J. Pharm, vol.740, pp.364-378, 2014.

P. B. Chapman, A. Hauschild, C. Robert, J. B. Haanen, P. Ascierto et al., Improved survival with vemurafenib in melanoma with BRAF V600E mutation, N. Engl. J. Med, vol.364, pp.2507-2516, 2011.

E. Maverakis, L. A. Cornelius, G. M. Bowen, T. Phan, F. B. Patel et al., Metastatic melanoma-A review of current and future treatment options, Acta Derm. Venereol, vol.95, pp.516-524, 2015.

M. Bidet, O. Joubert, B. Lacombe, R. Nehmé, P. Mollat et al., Mus-Veteau, I. The Hedgehog Receptor Patched Contributes to Cholesterol Efflux, PLoS ONE, vol.6, 2011.

H. Qian, P. Cao, M. Hu, S. Gao, N. Yan et al., Inhibition of tetrameric Patched1 by Sonic Hedgehog through an asymmetric paradigm, Nat. Commun, vol.10, 2019.

G. Bollag, P. Hirth, J. Tsai, J. Zhang, P. N. Ibrahim et al., Clinical efficacy of a RAF inhibitor needs broad target blockade in BRAF-mutant melanoma, Nature, vol.467, pp.596-599, 2010.

I. Wortzel and R. Seger, The ERK cascade: Distinct functions within various subcellular organelles, Genes Cancer, vol.2, pp.195-209, 2011.

J. Tsai, J. T. Lee, W. Wang, J. Zhang, H. Cho et al., Discovery of a selective inhibitor of oncogenic B-Raf kinase with potent antimelanoma activity, Proc. Natl. Acad. Sci, vol.105, pp.3041-3046, 2008.

G. C. Leonardi, L. Falzone, R. Salemi, A. Zanghì, D. A. Spandidos et al., Cutaneous melanoma: From pathogenesis to therapy (Review), Int. J. Oncol, vol.52, pp.1071-1080, 2018.

H. Davies, G. R. Bignell, C. Cox, P. Stephens, S. Edkins et al., Mutations of the BRAF gene in human cancer, Nature, vol.417, pp.949-954, 2002.

K. T. Flaherty, I. Puzanov, K. B. Kim, A. Ribas, G. A. Mcarthur et al., Inhibition of mutated, activated BRAF in metastatic melanoma, N. Engl. J. Med, vol.363, pp.809-819, 2010.

K. T. Flaherty, J. R. Infante, A. Daud, R. Gonzalez, R. F. Kefford et al., Combined BRAF and MEK inhibition in melanoma with BRAF V600 mutations, N. Engl. J. Med, vol.367, pp.1694-1703, 2012.

K. K. Broman, L. A. Dossett, J. Sun, Z. Eroglu, and J. S. Zager, Update on BRAF and MEK inhibition for treatment of melanoma in metastatic, unresectable, and adjuvant settings, Expert Opin. Drug Saf, vol.18, pp.381-392, 2019.

S. Kakadia, N. Yarlagadda, R. Awad, M. Kundranda, J. Niu et al., Mechanisms of resistance to BRAF and MEK inhibitors and clinical update of US Food and Drug Administration-approved targeted therapy in advanced melanoma, Onco Targets Ther, vol.11, pp.7095-7107, 2018.

T. Strub, R. Ballotti, and C. Bertolotto, The Art of Epigenetics in Melanoma: From histone "Alterations, to Resistance and Therapies, Theranostics 2020, vol.10, pp.1777-1797
URL : https://hal.archives-ouvertes.fr/inserm-02529724

A. A. Stavrovskaya and E. Y. Rybalkina, Recent Advances in the Studies of Molecular Mechanisms Regulating Multidrug Resistance in Cancer Cells, Biochemistry, vol.83, pp.779-786, 2018.

M. M. Gottesman, Mechanisms of cancer drug resistance, Annu. Rev. Med, vol.53, pp.615-627, 2002.

S. Avram, D. E. Coricovac, I. Z. Pavel, I. Pinzaru, R. Ghiulai et al., Standardization of A375 human melanoma models on chicken embryo chorioallantoic membrane and Balb/c nude mice, Oncol. Rep, vol.38, pp.89-99, 2017.

D. Coricovac, C. Dehelean, E. A. Moaca, I. Pinzaru, T. Bratu et al., Cutaneous Melanoma-A Long Road from Experimental Models to Clinical Outcome: A Review, Int. J. Mol. Sci, vol.19, 1566.

O. F. Kuzu, M. A. Noory, and G. P. Robertson, The Role of Cholesterol in Cancer, Cancer Res, vol.76, pp.2063-2070, 2016.

S. C. Lim, K. R. Parajuli, H. Q. Duong, J. E. Choi, and S. I. Han, Cholesterol induces autophagic and apoptotic death in gastric carcinoma cells, Int. J. Oncol, vol.44, pp.805-811, 2014.

I. Tabas, Consequences of cellular cholesterol accumulation: Basic concepts and physiological implications, J. Clin. Investig, vol.110, pp.905-911, 2002.

S. Riniker and G. A. Landrum, Better Informed Distance Geometry: Using What We Know To Improve Conformation Generation, J. Chem. Inf. Model, vol.55, pp.2562-2574, 2015.

, Genomic Classification of Cutaneous Melanoma, Cell, vol.161, pp.1681-1696, 2015.

A. Lipton, W. J. Köstler, K. Leitzel, S. M. Ali, J. Sperinde et al., Quantitative HER2 protein levels predict outcome in fluorescence in situ hybridization-positive patients with metastatic breast cancer treated with trastuzumab, Cancer, vol.116, pp.5168-5178, 2010.

O. Trott and A. J. Olson, AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization and multithreading, J. Comput. Chem, pp.455-461, 2010.

E. F. Pettersen, T. D. Goddard, C. C. Huang, G. S. Couch, D. M. Greenblatt et al., UCSF Chimera-a visualization system for exploratory research and analysis, J. Comput. Chem, vol.25, pp.1605-1612, 2004.

M. V. Shapovalov and J. R. Dunbrack, A smoothed backbone-dependent rotamer library for proteins derived from adaptive kernel density estimates and regressions, Structure, vol.19, pp.844-858, 2011.

J. Wang, W. Wang, P. A. Kollman, and D. A. Case, Automatic atom type and bond type perception in molecular mechanical calculations, J. Mol. Graph. Modeling, vol.25, pp.247-260, 2006.

H. M. Dingerdissen, J. Torcivia-rodriguez, Y. Hu, T. C. Chang, R. Mazumder et al., BioMuta and BioXpress: Mutation and expression knowledgebases for cancer biomarker discovery, Nucleic Acids Res, vol.46, pp.1128-1136, 2017.

K. Stierand, P. C. Maass, and M. Rarey, Molecular Complexes at a Glance: Automated Generation of two-dimensional Complex Diagrams, Bioinformatics, vol.22, pp.1710-1716, 2006.

R. Fährrolfes, S. Bietz, F. Flachsenberg, A. Meyder, E. Nittinger et al., Proteins Plus: A web portal for structure analysis of macromolecules, Nucleic Acids Res, vol.45, pp.337-343, 2017.

J. M. Chang, P. Di-tommaso, J. F. Taly, and C. Notredame, Accurate multiple sequence alignment of transmembrane proteins with PSI-Coffee, BMC Bioinform, vol.13, 2012.

K. Jawinski, M. Hartmann, C. Singh, E. Kinnear, D. C. Busse et al., Recombinant Haemagglutinin Derived From the Ciliated Protozoan Tetrahymena thermophila Is Protective Against Influenza Infection, Front. Immunol, vol.10, 2019.

J. Folch, M. Lees, and G. H. Sloane-stanley, A simple method for the isolation and purification of total lipides from animal tissues, J. Biol. Chem, vol.226, pp.497-509, 1957.